Pharmafile Logo

Maximising patient adherence by leveraging the patient/ physician/ pharma relationship

Director Marc Yates looks at the problem of patient compliance – can a better understanding of patient attitudes, needs and behaviours help pharma develop strategies to improve adherence?

Consider the scenario – the physician has been detailed, is sold on your brand’s benefits and prescribes it to the patient. Unfortunately the patient, perhaps unconvinced of what the drug will do for them, either doesn’t fill the prescription or fails to adhere properly to the treatment regime – that’s assuming they even present in the first place. It’s a common problem, especially for chronic diseases like diabetes, hypertension and osteoporosis, and one the pharmaceutical industry has invested much time and money trying to solve. Some companies have responded by developing sophisticated technological solutions, such as wireless devices, that remind patients when to take their medication. Unfortunately these solutions have not raised adherence levels because they have failed to get to the heart of the matter. To develop an effective adherence strategy, you first need to develop a more in-depth understanding of the attitudes and behaviours of both the patient and the physician, and the relationship which exists between them.

Download and read the complimentary whitepaper at http://bit.ly/1R0gWjr

We are one of the largest independent healthcare market research and consulting agencies in the world. Trusted partner to the global pharmaceutical industry, we use our expertise and experience to deliver intelligent, tailor-made solutions. We provide strategic recommendations that go beyond research, helping our clients to answer their fundamental business challenges.
 

This content was provided by Research Partnership

Company Details

 Latest Content from  Research Partnership 

Guide

UX research

Article: Why pharma must trust the science of behaviour

In a recent interview with PME Magazine, Dan Coffin, Director explains why the application of behavioural science will be key to better health far beyond COVID-19.Read the full article here:...

Case study

Using qualitative conjoint to assess willingness-to-pay

Consumer health specialist joins Research Partnership Inc

Global healthcare market research consultancy Research Partnership has appointed Jennifer Stewart as a Director in their US offices in Philadelphia.

Article: What's next? How behavioural science can support pharma's future

Dan Coffin, Director explains why now is an opportune time for pharma marketers to embrace behavioural science. Read his latest article for PME Magazine.https://bit.ly/31ef6rh

Video: UX/ Experience design research

Director and UX expert Liza Pliss discusses Research Partnership's approach to user experience research and shares an example of a project where using design thinking led to an agile approach...

White paper: The impact of COVID-19 on chronic disease management

Therapy Watch, Research Partnership's syndicated PRF tracker, has been investigating the impact of COVID-19 on chronic disease management. In this white paper, Research Partnership share some of the insights and...

Article: Pricing a coronavirus vaccine

Using findings from Research Partnership's recent COVID-19 impact study, Market Access Directors Rachel Howard and Brett Gardiner and Consultant Suzan Serip explore the challenges of pricing a coronavirus vaccine. Read...

News: Living with Ulcerative Colitis and Crohn's Disease

Living with Ulcerative Colitis (UC) and Crohn’s Disease (CD) are new patient syndicated reports which offer valuable insights into patient attitudes and behaviour towards their condition, treatments and unmet needs. These reports...

Interactive infographic

Living With: The journey from the patient’s perspective